Cytostatic treatment of nephrotic syndrome in children.
D000293:Adolescent; D000505:Alopecia / Q000139:chemically induced; D002648:Child; D002850:Chromatography, Gel; D002869:Chromosome Aberrations; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D003556:Cystitis / Q000139:chemically induced; D004338:Drug Combinations; D004590:Electrophoresis, Paper; D005260:Female; D005921:Glomerulonephritis / Q000473:pathology; D006417:Hematuria; D006801:Humans; D007122:Immunoelectrophoresis; D007136:Immunoglobulins / Q000032:analysis; D007678:Kidney Glomerulus / Q000473:pathology; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy* / Q000473:pathology; D011239:Prednisolone / Q000627:therapeutic use*; D011379:Prognosis; D011507:Proteinuria; D012075:Remission, Spontaneous
D004338:Drug Combinations; D007136:Immunoglobulins; D003520:Cyclophosphamide; D011239:Prednisolone